DALLAS--(BUSINESS WIRE)--
Lantern Pharma is excited to announce that it has been selected as a
"2018 TiE50 winner" for the prestigious TiE50 Awards Program recognizing
the world's most innovative tech startups. This awards competition is
part of TiE Inflect 2018, the world's largest conference for tech
entrepreneurs.
“It’s an honor to be recognized by fellow entrepreneurs and VCs from
Silicon Valley. I thank TiE for this appreciation,” Arun Asaithambi,
Co-Founder, Lantern said. “I am looking forward to receiving the award
and sharing Lantern's story with the TiE Inflect attendees. Lantern is
leveraging data and AI technologies for patient stratification and
precision drug development.”
"TiE50 has become a global brand that attracts thousands of tech
startups worldwide. This year, we screened more than 7400 companies from
28 countries and selected the best-of-breed as our '2018 TiE50
Finalists.' These companies are finalists in the ultimate runoff for the
50 winners. Our program has gained notoriety over the past decade as a
competition run with the highest level of integrity and vigorous
screening and judging by domain experts," said Kamal Anand, TiE50
Program Chair.
"As a 26-year not-for-profit dedicated to fostering entrepreneurship and
with a global footprint of half million entrepreneurs, enterprise
executives, and investment professionals, we pride in the fact that we
are one of very few competitions without any pay-to-play incentives,"
said Ram K. Reddy, President, TiE Silicon Valley.
About TiE Inflect 2018:
TiE Inflect (previously TiEcon) is the world's largest conference for
entrepreneurs and intrapreneurs with participation from top technology
companies, leading venture capital firms, and global services providers.
TiEcon 2017 attracted 5400+ attendees from across the world - including
CEOs of established companies to first-time entrepreneurs creating new
companies, to leading investment professionals and corporate executives.
The conference was listed by Worth Magazine as one of the 10 best
conferences for ideas and entrepreneurship along with TED and the World
Economic Forum. For more information, please visit http://www.tieinflect.org.
About TiE:
The Indus Entrepreneurs (TiE) is a not-for-profit founded in 1992 in the
Silicon Valley by a group of successful entrepreneurs, corporate
executives, and senior professionals. TiE is the world's largest network
of tech entrepreneurs. We are a cohesive global network with a footprint
of half million entrepreneurs, enterprise executives, investment
professionals, and other accomplished individuals. We operate from 60
cities in 16 countries. http://www.tieeco.org.
About Lantern Pharma Inc
Lantern Pharma is a late clinical stage precision oncology company that
is using proprietary AI tech platform to identify drug specific genetic
signatures (potential CDX) for patient stratification with a high
prediction accuracy for focused precision clinical trials. RADR is
integrating clinical data, with data generated from wet-lab approach
closely modeling real world evidence/clinical trials and machine
learning to identify genetic signatures and potential responders to the
drug. Lantern's approach can improve success of the drug, lower
developmental costs and time many folds vs traditional drug
developmental processes.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180501006186/en/
Lantern Pharma
Arun Asaithambi
info@lanternpharma.com
Source: Lantern Pharma
Released May 1, 2018